Reports for NALOXONE

Ingredient

NALOXONE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-03-28 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Actual shortage 2024-03-07 2024-03-28 221537
SUBOXONE 1MG 4MG FILM, SOLUBLE Resolved 2023-06-12 2023-07-05 194776
SUBOXONE 2MG 8MG FILM, SOLUBLE Resolved 2023-04-13 2023-05-19 189554
SUBOXONE 0.5MG 2MG FILM, SOLUBLE Resolved 2023-03-02 2023-04-29 186034
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
PMS-BUPRENORPHINE-NALOXONE 8MG 2MG TABLET Resolved 2019-10-04 2022-01-17 95445
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363

Showing 1 to 10 of 23

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048

Showing 1 to 2 of 2